Company / Current Assets
Lilly (Eli) Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$55.6B
FY2025
5-year range
$18.0B / $55.6B
FY2021-FY2025
Trend
+69.9%
vs FY2024
Sector context
#1 of 213
Health Care
What the data says
Among 213 Health Care companies, Lilly (Eli) is in the top 0% for current assets. Current Assets has increased for 3 consecutive years, from $18.0B in FY2022 to $55.6B in FY2025.
Based on SEC 10-K filings.
$55.6B in FY2025 with a 5-year CAGR of +26.1%. Ranks 1st among 213 companies in Health Care.
Improved from $25.7B to $55.6B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +45.6%
- 5-Year CAGR
- +26.1%
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 213This company $55.6B Sector average $2.5B
▼
+2105.1% above sector average
Key checks
Key Insights
- Lilly (Eli)'s current assets has grown for 3 consecutive years.
- 5-year CAGR of +26.1%, indicating consistent growth.
- In FY2025, current assets increased 69.9% year-over-year.
- Ranks #1 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- Strong profit margin: 31.0%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 77.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $55.6B | +69.9% |
| FY2024 | $32.7B | +27.3% |
| FY2023 | $25.7B | +42.7% |
| FY2022 | $18.0B | -2.3% |
| FY2021 | $18.5B | +5.7% |
| FY2020 | $17.5B | +27.4% |
| FY2019 | $13.7B | -33.3% |
| FY2018 | $20.5B | +7.0% |
| FY2017 | $19.2B | +27.2% |
| FY2016 | $15.1B | +20.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026